Abivax S.A. (ABVX)
Healthcare
Biotechnology
124.80 $
-0.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Abivax S.A. (ABVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -51 million EUR. Tick rows to compare them in a chart.
All figures in millions of EUR.
| Tick rows to compare them in a chart (up to 4) | Q1 23 | Q2 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -28 | -71 | -35 | -43 | -35 | -69 | -33 | -67 | -71 | -71 | -51 | -260 | |
| 0.2 | 0.3 | 0.4 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.5 | 0.3 | 0.5 | 0.4 | 1.7 | |
| – | 0.1 | – | 5.8 | 5.7 | 4.3 | 8.8 | 4.7 | 11 | 11 | -11 | 23 | 34 | |
| 7.4 | 7.4 | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.4 | 12 | 3.9 | 2.0 | 10 | 0.6 | 9.0 | 2.3 | -2.1 | 1.2 | -5.0 | -3.5 | |
| 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.3 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | |
| -0.9 | -1.7 | -8.8 | – | 13 | – | 1.2 | – | 1.3 | – | 3.3 | – | – | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | – | – | – | – | – | – | – | – | |
| -2.6 | -2.6 | – | 22 | 20 | -2.9 | -2.2 | -6.1 | -6.9 | -5.7 | -41 | -0.4 | -54 | |
| 58 | 118 | 223 | 21 | 40 | -6.3 | -12 | -7.8 | -8.8 | 603 | 603 | 0.1 | 1,198 | |
| 44 | 87 | 138 | -10 | -19 | -42 | -41 | -41 | 61 | 529 | 529 | -39 | 1,079 | |
| – | -29 | -71 | -35 | -43 | -36 | -69 | -33 | -67 | -71 | -71 | -51 | -260 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.